Cargando…
Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex
The native Invaplex (Invaplex(NAT)) vaccine and adjuvant is an ion exchange-purified product derived from the water extract of virulent Shigella species. The key component of Invaplex(NAT) is a high-molecular-mass complex (HMMC) consisting of the Shigella lipopolysaccharide (LPS) and the invasin pro...
Autores principales: | Turbyfill, K. Ross, Clarkson, Kristen A., Vortherms, Anthony R., Oaks, Edwin V., Kaminski, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874444/ https://www.ncbi.nlm.nih.gov/pubmed/29600284 http://dx.doi.org/10.1128/mSphere.00583-17 |
Ejemplares similares
-
Development of the Shigella flexneri 2a, 3a, 6, and S. sonnei artificial Invaplex (Invaplex(AR)) vaccines
por: Turbyfill, K. Ross, et al.
Publicado: (2023) -
From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine’s Refinement and Evolution
por: Turbyfill, K. Ross, et al.
Publicado: (2022) -
Invaplex functions as an intranasal adjuvant for subunit and DNA vaccines co-delivered in the nasal cavity of nonhuman primates
por: Camp, Jeremy V., et al.
Publicado: (2021) -
Adjuvants and adjuvanticity
por: Tizard, Ian R.
Publicado: (2021) -
Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei
por: Clarkson, Kristen A., et al.
Publicado: (2021)